Computational molecular docking assessment of hormone receptor adjuvant drugs: Breast cancer as an example.

Author: MajumderDurjoy, MukherjeeSayan

Paper Details 
Original Abstract of the Article :
For the maintenance therapy of breast cancer, drugs which act as antagonists/partial agonists of hormone receptors against the breast tissue are used in the conventional clinical practices. However, during the course of treatment the patients may encounter systems related complications. Drugs like t...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.pathophys.2008.12.001

データ提供:米国国立医学図書館(NLM)

Hormone Receptor Adjuvant Drugs: Exploring the Desert of Potential Side Effects

Breast cancer, a challenging disease that affects many women, often requires hormone receptor adjuvant drugs as part of its treatment. This study, like a camel navigating the vast desert of drug interactions, investigates the potential side effects of these drugs by using molecular docking methods. The study examines the binding of commonly used drugs like tamoxifen, raloxifene, toremifene, and mifepristone to various receptors in the body. The study found that these drugs exhibit varying degrees of binding affinity to various receptors, potentially explaining their observed toxicities.

Hormone Receptor Adjuvant Drugs: Unveiling the Hidden Landscape of Potential Side Effects

This study provides valuable insights into the potential side effects of commonly used hormone receptor adjuvant drugs for breast cancer. The study’s findings highlight the importance of carefully monitoring patients for potential complications and considering alternative treatment options when necessary.

Navigating the Desert: Awareness and Informed Choices

This research underscores the need for a comprehensive understanding of the potential side effects of hormone receptor adjuvant drugs. Just as a camel navigates a desert landscape with caution, individuals undergoing breast cancer treatment should consult with their healthcare providers to discuss potential risks and benefits.

Dr. Camel's Conclusion

This study reminds us that the journey to combatting breast cancer is not always straightforward. Like a camel navigating a desert, researchers continue to explore the complexities of drug interactions, aiming to minimize potential side effects and maximize treatment effectiveness.

Date :
  1. Date Completed 2012-10-02
  2. Date Revised 2020-09-29
Further Info :

Pubmed ID

19147336

DOI: Digital Object Identifier

10.1016/j.pathophys.2008.12.001

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.